Dose-dependent association of naldemedine and magnesium oxide in the management of opioid-induced constipation. [PDF]
Hoshino R +6 more
europepmc +1 more source
Practical guidance for navigating buprenorphine discontinuation. [PDF]
Sonoda K, Hilmer AB, Bello JK.
europepmc +1 more source
Mu or delta opioid receptor antagonists increase the expression of social conditioned place preference in early adolescent mice. [PDF]
Harda Z +9 more
europepmc +1 more source
Treatment of Opioid-Induced Constipation: Inducing Laxation and Understanding the Risk of Gastrointestinal Perforation. [PDF]
Mehta N +3 more
europepmc +1 more source
Examining Removal of Federal Waiver Restrictions to Prescribing Buprenorphine in Primary Care. [PDF]
Simon CB +8 more
europepmc +1 more source
Comparative Effectiveness of Naltrexone Formulations in Alcohol Use Disorder: An Updated Meta-Analysis. [PDF]
Nunez NA, Ali HM, Hassett L, Singh B.
europepmc +1 more source
Modeling Supports Combinatorial Effects Between Pharmacological and Non-Pharmacological Interventions to Prevent Opioid-Induced Cardiac Arrest. [PDF]
Thrasher B +12 more
europepmc +1 more source
Naloxone administration associated with improved survival in PEA out-of-hospital cardiac arrests. [PDF]
Niederberger SM +6 more
europepmc +1 more source
PAMORAs in Opioid-Induced Constipation: Are We Following the Guidelines? [PDF]
Liu K +5 more
europepmc +1 more source
Optimizing Pharmacotherapy During Implementation of Enhanced Recovery After Surgery (ERAS) in Ambulatory Urologic Oncology Surgery: Narrative Review. [PDF]
Shook JK +3 more
europepmc +1 more source

